Roy N. Alcalay

Also affiliated with Columbia University Irving Medical Center, Tel Aviv Sourasky Medical Center

MedicineNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile

1.3Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort

npj Parkinson s Disease(2022)10.1038/s41531-022-00404-w

Top 26%

0.783DataRank

Top 26%19 citations

Kalpana Merchant, Michael C. Brumm, Hyunkeun Cho, Chelsea Caspell‐Garcia, Christopher S. Coffey +85 more

Papers

Driven by 76 papers — median percentile 48. Top paper: “Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients with Parkinson’s Disease and a GBA Mutation: Results from Part 1 of the Randomized, Double-Blinded, Placebo-Controlled MOVES-PD Trial”.

Safety, Pharmacokinetics, and Pharmacodynamics of Oral Venglustat in Patients with Parkinson’s Disease and a GBA Mutation: Results from Part 1 of the Randomized, Double-Blinded, Placebo-Controlled MOVES-PD Trial

Journal of Parkinson s Disease(2021)10.3233/jpd-212714

N/A

1.7DataRank · unranked

61 citations

on behalf of the MOVES-PD Investigators, Hidemoto Saiki, Taku Hatano, Thomas Gasser, Stuart Isaacson +17 more

Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort

npj Parkinson s Disease(2022)10.1038/s41531-022-00404-w

Top 26%

0.783DataRank

Top 26%19 citations

Kalpana Merchant, Michael C. Brumm, Hyunkeun Cho, Chelsea Caspell‐Garcia, Christopher S. Coffey +85 more

Establishing an online resource to facilitate global collaboration and inclusion of underrepresented populations: Experience from the MJFF Global Genetic Parkinson’s Disease Project

PLoS ONE(2023)10.1371/journal.pone.0292180

Top 52%

0.332DataRank

Top 52%7 citations

Harutyun Madoev, Anna Aasly, Azlina Ahmad‐Annuar, Bashayer Al‐Mubarak, Roy N. Alcalay +78 more

Rare but Relevant? Assessing Variants in Dystonia‐Linked Genes in Parkinson's Disease

Movement Disorders(2025)10.1002/mds.70073

Top 70%

0.165DataRank

Top 70%2 citations

Zih‐Hua Fang, Laurel A. Screven, Ai Huey Tan, Roy N. Alcalay, Rim Amouri +33 more

Longitudinal Measurements of Glucocerebrosidase activity in Parkinson’s patients

Annals of Clinical and Translational Neurology(2020)10.1002/acn3.51164

N/A

0DataRank · unranked

40 citations

Pavlina Wolf, Ming Sum Ruby Chiang, Karolina Helesicova, Xiaokui Kate Zhang, Kalpana Merchant +15 more

Differences in performance on English and Hebrew versions of the MoCA in Parkinson's patients

Clinical Parkinsonism & Related Disorders(2020)10.1016/j.prdoa.2020.100042

N/A

0DataRank · unranked

9 citations

Anat Mirelman, Rachel Saunders‐Pullman, Helen Mejia‐Santana, Elise Caccappolo, Deborah Raymond +5 more

Genome-wide association studies of LRRK2 modifiers of Parkinson's disease

medRxiv(2020)10.1101/2020.12.14.20224378

N/A

0DataRank · unranked

10 citations

Babak Alipanahi, Pierre Fontanillas, Tae‐Hwi Schwantes‐An, Jan Aasly, Roy N. Alcalay +55 more

LRRK2 p.M1646T is associated with glucocerebrosidase activity and with Parkinson’s disease

medRxiv(2020)10.1101/2020.09.23.20197558

N/A

0DataRank · unranked

3 citations

Eric Yu, Lynne Krohn, Uladzislau Rudakou, Kheireddin Mufti, Jennifer A. Ruskey +11 more

Analysis of heterozygous PRKN variants and copy number variations in Parkinson’s disease

medRxiv(2020)10.1101/2020.05.07.20072728

N/A

0DataRank · unranked

2 citations

Uladzislau Rudakou, Lynne Krohn, Kheireddin Mufti, Jennifer A. Ruskey, Farnaz Asayesh +15 more

Association study of DNAJC13, UCHL1, HTRA2, GIGYF2 and EIF4G1 with Parkinson’s disease

medRxiv(2020)10.1101/2020.06.26.20141176

N/A

0DataRank · unranked

2 citations

Uladzislau Rudakou, Eric Yu, Jennifer A. Ruskey, Farnaz Asayesh, Sandra B. Laurent +15 more

Variants in the Niemann-Pick type C gene NPC1 are not associated with Parkinson’s disease

medRxiv(2020)10.1101/2020.03.06.20030734

N/A

0DataRank · unranked

0 citations

Konstantin Senkevich, Uladzislau Rudakou, Eric Yu, Kheireddin Mufti, Jennifer A. Ruskey +16 more

Lack of evidence for genetic association of saposins A, B, C and D with Parkinson disease

medRxiv(2020)10.1101/2020.05.31.20061010

N/A

0DataRank · unranked

0 citations

Sara Bandrés‐Ciga, Sharon Hassin, Roy N. Alcalay, Ziv Gan‐Or, Yuri L. Sosero

Identification of Candidate Parkinson Disease Genes by Integrating Genome-Wide Association Study, Expression, and Epigenetic Data Sets

JAMA Neurology(2021)10.1001/jamaneurol.2020.5257

N/A

0DataRank · unranked

205 citations

David Zhang, Sebastian Guelfi, Claudia Manzoni, Leon Hubbard, Regina Hertfelder Reynolds +85 more

α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson’s disease from multiple system atrophy

Acta Neuropathologica(2021)10.1007/s00401-021-02324-0

N/A

0DataRank · unranked

162 citations

Simon Hornung, Adira Kruayatidee, Katherine N. Maina, Irish Del Rosario, Kimberly C. Paul +18 more

Genomewide Association Studies of LRRK2 Modifiers of Parkinson's Disease

Annals of Neurology(2021)10.1002/ana.26094

N/A

0DataRank · unranked

50 citations

Babak Alipanahi, Pierre Fontanillas, Tae‐Hwi Schwantes‐An, Jan Aasly, Roy N. Alcalay +56 more

COVID-19 Vaccination for Persons with Parkinson’s Disease: Light at the End of the Tunnel?

Journal of Parkinson s Disease(2021)10.3233/jpd-212573

N/A

0DataRank · unranked

26 citations

Claudia Trenkwalder, Álvaro Sánchez‐Ferro, Lorraine V. Kalia, Roy N. Alcalay, Han-Lin Chiang +5 more

LRRK2 p.M1646T is associated with glucocerebrosidase activity and with Parkinson's disease

Neurobiology of Aging(2021)10.1016/j.neurobiolaging.2021.02.018

N/A

0DataRank · unranked

25 citations

Eric Yu, Lynne Krohn, Uladzislau Rudakou, Kheireddin Mufti, Jennifer A. Ruskey +11 more

Cytokines and Gaucher Biomarkers in Glucocerebrosidase Carriers with and Without Parkinson Disease

Movement Disorders(2021)10.1002/mds.28525

N/A

0DataRank · unranked

24 citations

Manisha Balwani, Stanley Fahn, Cheryl Waters, Lynne Krohn, Ziv Gan‐Or +3 more

Transcriptional analysis of peripheral memory T cells reveals Parkinson’s disease-specific gene signatures

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.05.28.446215

N/A

0DataRank · unranked

3 citations

João Rodrigues Lima-Júnior, Ashu Sethi, John Pham, Gregory P. Williams, April Frazier +11 more

Parkinson Disease and Subthalamic Nucleus Deep Brain Stimulation: Cognitive Effects in GBA Mutation Carriers

Annals of Neurology(2022)10.1002/ana.26302

N/A

0DataRank · unranked

100 citations

Graziella Mangone, Emily J. Hill, Bichun Ouyang, Yuanqing Liu, Vanessa Lythe +26 more

Transcriptional analysis of peripheral memory T cells reveals Parkinson’s disease-specific gene signatures

npj Parkinson s Disease(2022)10.1038/s41531-022-00282-2

N/A

0DataRank · unranked

50 citations

João Rodrigues Lima-Júnior, Ashu Sethi, John Pham, Gregory P. Williams, April Frazier +11 more

GALC variants affect galactosylceramidase enzymatic activity and risk of Parkinson’s disease

Brain(2022)10.1093/brain/awac413

N/A

0DataRank · unranked

39 citations

Cornelia E. Zorca, Aliza Dworkind, Uladzislau Rudakou, Emma N. Somerville, Eric Yu +24 more

Planning for Prevention of Parkinson Disease

Neurology(2022)10.1212/wnl.0000000000200789

N/A

0DataRank · unranked

30 citations

Jessi L. Keavney, Roy N. Alcalay, Kenneth Marek, Gad A. Marshall, H. Diana Rosas +2 more

Lipid level alteration in human and cellular models of alpha synuclein mutations

npj Parkinson s Disease(2022)10.1038/s41531-022-00313-y

N/A

0DataRank · unranked

22 citations

Cristina Guardia‐Laguarta, Matthew Surface, Nikolaos Papagiannakis, Matina Maniati, Roubina Antonellou +9 more

Unaltered T cell responses to common antigens in individuals with Parkinson's disease

Journal of the Neurological Sciences(2022)10.1016/j.jns.2022.120510

N/A

0DataRank · unranked

17 citations

Kaylin Muskat, April Frazier, Yaqian Xu, José Mateus, Alba Grifoni +11 more

Plasma Metabolite Signature Classifies Male LRRK2 Parkinson’s Disease Patients

Metabolites(2022)10.3390/metabo12020149

N/A

0DataRank · unranked

17 citations

Chandrashekhar Honrao, Leonardo O. Rodrigues, J. Wolf, Keri B. Sheehan, Matthew Surface +3 more

A cross-disease human microglial framework identifies disease-enriched subsets and tool compounds for microglial polarization

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.06.04.494709

N/A

0DataRank · unranked

21 citations

Mariko Taga, Verena Haage, Tina Roostaei, Charles C. White, Annie Lee +22 more

GALC variants affect galactosylceramidase enzymatic activity and risk of Parkinson’s disease

medRxiv(2022)10.1101/2022.04.30.22274239

N/A

0DataRank · unranked

3 citations

Cornelia E. Zorca, Aliza Dworkind, Uladzislau Rudakou, Emma N. Somerville, Eric Yu +24 more

Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers: The PPMI cohort

Research Square(2022)10.21203/rs.3.rs-1719882/v1

N/A

0DataRank · unranked

3 citations

Kalpana Merchant, Michael C. Brumm, Hyunkeun Cho, Chelsea Caspell‐Garcia, Christopher S. Coffey +11 more

Quantitative proteomics and phosphoproteomics of urinary extracellular vesicles define diagnostic biosignatures for Parkinson’s Disease

medRxiv(2022)10.1101/2022.01.18.22269096

N/A

0DataRank · unranked

2 citations

Li Li, Kananart Kuwaranancharoen, Xiaofeng Wu, Zheng-Chi Lee, Roy N. Alcalay +4 more

Urinary bis(monacylglycerol) phosphate (BMP) levels are higher in LRRK2 and GBA1 variant carriers but do not predict disease progression in PPMI cohorts

Research Square(2022)10.21203/rs.3.rs-2065993/v1

N/A

0DataRank · unranked

1 citations

Tanya Simuni, Janel Fedler, Chelsea Caspell‐Garcia, Michael C. Brumm, Kelly Nudelman +15 more

Toward a Biomarker Panel measured in CNS-originating Extracellular Vesicles for Improved Differential Diagnosis of Parkinson’s Disease and Multiple System Atrophy

Research Square(2022)10.21203/rs.3.rs-2375640/v1

N/A

0DataRank · unranked

1 citations

Simon Hornung, Suman Dutta, Leony Fenwick, Otmane Lahgui, Kathryn Howe +15 more

Polygenic Parkinson’s disease genetic risk score as risk modifier of parkinsonism in Gaucher disease

medRxiv(2022)10.1101/2022.12.19.22280175

N/A

0DataRank · unranked

1 citations

Nahid Tayebi, Elizabeth Geena Woo, Grisel Lopez, Luca Fierro, Marco Toffoli +15 more

Distinctive blood CD56bright NK cell subset profile and increased NKG2D expression in CD56bright NK cells in Parkinson’s disease

Research Square(2022)10.21203/rs.3.rs-1883506/v1

N/A

0DataRank · unranked

0 citations

Stephen Weber, Kelly B. Menees, Julian Agin‐Liebes, Chih-Chun Lin, Roy N. Alcalay +1 more

A blood-based marker of mitochondrial DNA damage in Parkinson’s disease

Science Translational Medicine(2023)10.1126/scitranslmed.abo1557

N/A

0DataRank · unranked

84 citations

Esther Sammler, Claudia P. González-Hunt, Ivana Barraza, Nicholas Pena, Jeremy P. Rouanet +24 more

Quantitative proteomics and phosphoproteomics of urinary extracellular vesicles define putative diagnostic biosignatures for Parkinson’s disease

Communications Medicine(2023)10.1038/s43856-023-00294-w

N/A

0DataRank · unranked

44 citations

Li Li, Kananart Kuwaranancharoen, Xiaofeng Wu, Zheng-Chi Lee, Roy N. Alcalay +4 more

LRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohorts

npj Parkinson s Disease(2023)10.1038/s41531-023-00468-2

N/A

0DataRank · unranked

42 citations

Tanya Simuni, Janel Fedler, Chelsea Caspell‐Garcia, Michael C. Brumm, Kelly Nudelman +16 more

Patterns of TDP‐43 Deposition in Brains with LRRK2 G2019S Mutations

Movement Disorders(2023)10.1002/mds.29449

N/A

0DataRank · unranked

20 citations

Richard A. Hickman, Jean Paul Vonsattel, Phyllis L. Faust, Xena Flowers, Irina Utkina Sosunova +8 more

Toward a biomarker panel measured in CNS-originating extracellular vesicles for improved differential diagnosis of Parkinson’s disease and multiple system atrophy

Translational Neurodegeneration(2023)10.1186/s40035-023-00346-0

N/A

0DataRank · unranked

30 citations

Simon Hornung, Suman Dutta, Leony Fenwick, Otmane Lahgui, Kathryn Howe +15 more

Polygenic Parkinson's Disease Genetic Risk Score as Risk Modifier of Parkinsonism in Gaucher Disease

Movement Disorders(2023)10.1002/mds.29342

N/A

0DataRank · unranked

20 citations

Nahid Tayebi, Elizabeth Geena Woo, Grisel Lopez, Luca Fierro, Marco Toffoli +15 more

International Genetic Testing and Counseling Practices for Parkinson's Disease

Movement Disorders(2023)10.1002/mds.29442

N/A

0DataRank · unranked

16 citations

Deborah Raymond, Roberto A. Ortega, Ali Shalash, Emilia Gatto, Mehri Salari +24 more

Association of Rare Variants in ARSA with Parkinson's Disease

Movement Disorders(2023)10.1002/mds.29521

N/A

0DataRank · unranked

14 citations

Mariia Beletskaia, Aliza Dworkind, Eric Yu, Jamil Ahmad, Jennifer A. Ruskey +20 more

The Parkinson’s disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neurons

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.11.11.566693

N/A

0DataRank · unranked

12 citations

Kathy He, Konstantin Senkevich, Nathan Karpilovsky, Ghislaine Deyab, Yuting Cousineau +29 more

RNA- and ATAC-sequencing Reveals a Unique CD83+ Microglial Population Focally Depleted in Parkinson’s Disease

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.05.17.540842

N/A

0DataRank · unranked

10 citations

Adhikrao Yadav, Jan Mareš, Xena Flowers, Taekyung yun, Md. Mamunur Rashid +14 more

Association of rare variants in ARSA with Parkinson’s disease

medRxiv(2023)10.1101/2023.03.08.23286773

N/A

0DataRank · unranked

4 citations

Mariia Beletskaia, Aliza Dworkind, Eric Yu, Jamil Ahmad, Jennifer A. Ruskey +19 more

Parkinson’s disease variant detection and disclosure: PD GENEration, a North American study

Brain(2024)10.1093/brain/awae142

N/A

0DataRank · unranked

93 citations

Jennifer Verbrugge, Tae‐Hwi Schwantes‐An, Jeanine Schulze, Tatiana Foroud, Anne Hall +31 more

Long-Term Dementia Risk in Parkinson Disease

Neurology(2024)10.1212/wnl.0000000000209699

N/A

0DataRank · unranked

76 citations

Caroline Gochanour, Chelsea Caspell‐Garcia, Roseanne D. Dobkin, Dag Aarsland, Roy N. Alcalay +88 more

Sensitivity and specificity of a seed amplification assay for diagnosis of multiple system atrophy: a multicentre cohort study

The Lancet Neurology(2024)10.1016/s1474-4422(24)00395-8

N/A

0DataRank · unranked

73 citations

Carly M. Farris, Sandrina Weber, Sebastian Schade, Hieu Nguyen, Alexandra Pérez‐Soriano +29 more

A cross-disease resource of living human microglia identifies disease-enriched subsets and tool compounds recapitulating microglial states

Nature Neuroscience(2024)10.1038/s41593-024-01764-7

N/A

0DataRank · unranked

51 citations

Mariko Taga, Verena Haage, Victoria Marshe, Tina Roostaei, Charles C. White +25 more

Genome sequence analyses identify novel risk loci for multiple system atrophy

Neuron(2024)10.1016/j.neuron.2024.04.002

N/A

0DataRank · unranked

44 citations

Anindita Ray, Zalak Shah, Jinhui Ding, Paola Ruffo, Masashi Fujita +95 more

The Parkinson’s disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neurons

Molecular Neurodegeneration(2024)10.1186/s13024-024-00779-9

N/A

0DataRank · unranked

33 citations

Kathy He, Nathan Karpilovsky, Konstantin Senkevich, Ghislaine Deyab, Isabella Pietrantonio +30 more

PINK1 is a target of T cell responses in Parkinson’s disease

Journal of Clinical Investigation(2024)10.1172/jci180478

N/A

0DataRank · unranked

21 citations

Antoine Freuchet, T. Michaelis, April Frazier, Ngan K. Tran, João Rodrigues Lima-Júnior +10 more

Exome sequencing in Asian populations identifies low-frequency and rare coding variation influencing Parkinson’s disease risk

Nature Aging(2024)10.1038/s43587-024-00760-7

N/A

0DataRank · unranked

15 citations

Zhehao Liu, Zheng Li, Sun Ju Chung, Michelle Mulan Lian, Moses Tandiono +45 more

Distinctive CD56dim NK subset profiles and increased NKG2D expression in blood NK cells of Parkinson’s disease patients

npj Parkinson s Disease(2024)10.1038/s41531-024-00652-y

N/A

0DataRank · unranked

14 citations

Kelly B. Menees, Jieun Park, Julian Agin‐Liebes, Chih-Chun Lin, Roy N. Alcalay +2 more

Participant-reported personal utility of genetic testing for Parkinson’s disease and interest in clinical trial participation

npj Parkinson s Disease(2024)10.1038/s41531-024-00805-z

N/A

0DataRank · unranked

5 citations

Lola Cook, Tae‐Hwi Schwantes‐An, Laurence E. Walsh, Anne‐Marie Wills, Ignácio F. Mata +7 more

Unmet Need in Early-Onset Parkinson’s Disease: Deep Brain Stimulation and Pregnancy

Journal of Parkinson s Disease(2024)10.3233/jpd-240088

N/A

0DataRank · unranked

5 citations

Raja Mehanna, Jori Fleisher, Roy N. Alcalay, Kishore R. Kumar, Connie Marras +10 more

Skin α‐Synuclein Seeding Activity in Patients with Type 1 Gaucher Disease

Movement Disorders(2024)10.1002/mds.29935

N/A

0DataRank · unranked

3 citations

Zerui Wang, Gadi Maayan Eshed, Luca Fierro, Chanan Stauffer, Kelly Wang +6 more

Effect of GBA1 Mutations and APOE Polymorphisms on Survival and Progression Among Ashkenazi Jews with Dementia with Lewy Bodies

Movement Disorders(2024)10.1002/mds.30003

N/A

0DataRank · unranked

1 citations

Gitit Kavé, Anat Mirelman, Keren Regev, Yoav Piura, Orly Goldstein +8 more

PINK1 is a target of T cell responses in Parkinson’s disease

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.02.09.579465

N/A

0DataRank · unranked

10 citations

T. Michaelis, João Rodrigues Lima-Júnior, April Frazier, Ngan K. Tran, Elizabeth J. Phillips +9 more

LRRK2-Associated Parkinsonism With and Without In Vivo Evidence of Alpha-Synuclein Aggregates

medRxiv(2024)10.1101/2024.07.22.24310806

N/A

0DataRank · unranked

4 citations

David-Erick Lafontant, Seung Ho Choi, Hirotaka Iwaki, Cornelis Blauwendraat, Andrew Singleton +20 more

Genome-wide association study of glucocerebrosidase activity modifiers

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.03.27.586821

N/A

0DataRank · unranked

1 citations

Lynne Krohn, Konstantin Senkevich, Eric Yu, Jamil Ahmad, Farnaz Asayesh +8 more

Are rare heterozygous SYNJ1 variants associated with Parkinson’s disease?

medRxiv(2024)10.1101/2024.05.29.24307986

N/A

0DataRank · unranked

0 citations

Sitki Cem Parlar, Cloe Chantereault, Eric Yu, Jamil Ahmad, Jennifer A. Ruskey +15 more

Impact of dopamine deficiency and REM sleep behavior disorder on cognition in early neuronal synuclein disease with hyposmia

medRxiv(2024)10.1101/2024.12.12.24318917

N/A

0DataRank · unranked

0 citations

Anuprita R Nair, Ryan Kurth, Michael C. Brumm, Michele K. York, Roseanne D. Dobkin +20 more

Classification and Genotype–Phenotype Relationships of GBA1 Variants: MDSGene Systematic Review

Movement Disorders(2025)10.1002/mds.30141

N/A

0DataRank · unranked

27 citations

Susen Schaake, Tatiana Usnich, Johann Boehm, Nina Steffen, Nathalie Schell +11 more

Plasma Glucosylceramide Levels Are Regulated by ATP10D and Are Not Involved in Parkinson's Disease Pathogenesis

Annals of Neurology(2025)10.1002/ana.27219

N/A

0DataRank · unranked

5 citations

Alva James, Christian Beetz, Robert Schwieger, Gal Barrel, Krishna Kumar Kandaswamy +9 more

Genome-Wide Association Study of Glucocerebrosidase Activity Modifiers

Molecular Neurobiology(2025)10.1007/s12035-025-04996-1

N/A

0DataRank · unranked

3 citations

Lynne Krohn, Konstantin Senkevich, Eric Yu, Jamil Ahmad, Farnaz Asayesh +8 more

Differential memory enrichment of cytotoxic CD4 T cells in Parkinson’s disease patients reactive to α-synuclein

npj Parkinson s Disease(2025)10.1038/s41531-025-00981-6

N/A

0DataRank · unranked

4 citations

Emil Johansson, April Frazier, Irene Litvan, Jennifer G. Goldman, Roy N. Alcalay +4 more

Clinical and imaging characteristics of Parkinson’s disease with negative alpha-synuclein seed amplification assay

medRxiv(2025)10.1101/2025.10.01.25337085

N/A

0DataRank · unranked

1 citations

Jacopo Pasquini, Seung Ho Choi, David-Erick Lafontant, Seyed‐Mohammad Fereshtehnejad, Yashar Zeighami +25 more

Lack of association between G6PD variants and Parkinson’s disease

medRxiv(2025)10.1101/2025.04.23.25324774

N/A

0DataRank · unranked

0 citations

Sitki Cem Parlar, Lang Liu, Leonard L. Sokol, Eric Yu, Farnaz Asayesh +18 more

Rare but Relevant: Assessing Variants in Dystonia-linked Genes in Parkinson’s Disease

medRxiv(2025)10.1101/2025.07.10.25330831

N/A

0DataRank · unranked

0 citations

Zih‐Hua Fang, Laurel A. Screven, Ai Huey Tan, Roy N. Alcalay, Rim Amouri +33 more

Stable two-year longitudinal clinical outcomes in LRRK2 G2019S non-manifest carriers in a remote nationwide study

Parkinsonism & Related Disorders(2025)10.1016/j.parkreldis.2025.107969

N/A

0DataRank · unranked

0 citations

Peggy Auinger, Meghan Pawlik, Emily Hartman, Saloni Sharma, Blanca Valdovinos +11 more

Cerebrospinal fluid proteomics implicates the granin family in Parkinson’s disease

Scientific Reports(2020)10.1038/s41598-020-59414-4

N/A

0DataRank · unranked

103 citations

Monica Lane, Wenfei Zhang, Pavlina Wolf, Petra Oliva, Catherine Viel +7 more

How many do we miss? - Evaluation of age at onset and family history as selection criteria for genetic testing in Parkinson’s disease

medRxiv(2025)10.1101/2025.11.15.25339249

N/A

0DataRank · unranked

0 citations

Eva‐Juliane Vollstedt, Ana Westenberger, Lara M. Lange, Joanne Trinh, Meike Kasten +12 more

Targeted sequencing of Parkinson’s disease loci genes highlights SYT11, FGF20 and other associations

Brain(2020)10.1093/brain/awaa401

N/A

0DataRank · unranked

56 citations

Eric Yu, Lynne Krohn, Jennifer A. Ruskey, Farnaz Asayesh, Yves Dauvilliers +11 more

Analysis of Heterozygous PRKN Variants and Copy‐Number Variations in Parkinson's Disease

Movement Disorders(2020)10.1002/mds.28299

N/A

0DataRank · unranked

49 citations

Uladzislau Rudakou, Lynne Krohn, Kheireddin Mufti, Jennifer A. Ruskey, Farnaz Asayesh +15 more

Association study of DNAJC13, UCHL1, HTRA2, GIGYF2, and EIF4G1 with Parkinson's disease

Neurobiology of Aging(2020)10.1016/j.neurobiolaging.2020.10.019

N/A

0DataRank · unranked

44 citations

Uladzislau Rudakou, Eric Yu, Jennifer A. Ruskey, Farnaz Asayesh, Sandra B. Laurent +15 more

Roy N. Alcalay

Indexed papers

Top data-sharing exemplar

Papers